The Use of Cyclosporin A in clinical Organ Grafting
- 1 September 1982
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 196 (3), 330-337
- https://doi.org/10.1097/00000658-198209000-00012
Abstract
Experiments in animals with organ allografts showed that Cyclosporin A (CyA) was an extremely powerful immunosuppressant with a good therapeutic index. A pilot study of the drug in human recipients of renal allografts revealed an unexpected side effect, nephrotoxicity, which made care of patients difficult. Following a policy of deliberate hydration of patients in the perioperative phase and withholding CyA until diuresis was occurring in the graft, excellent results have been obtained in clinical practice. An 82% actuarial functional survival at both one and two years has been obtained in the 59 patients treated with this protocol. A multicenter trial is now in progress in eight centers in Europe, comparing CyA used in the manner described above with conventional azathioprine and steroids. CyA has also been used in 17 recipients of liver allografts, ten of whom are still alive and 11 recipients of segmental pancreatic allografts, one of whom remains off insulin after two and a quarter years. Sudden graft failure occurred between three months and two years in three patients whose pancreatic duct had been occluded. The authors' most recent segmental pancreas graft has been drained into a long roux loop without complications. The main objective in the use of this drug is to obtain consistent immunosuppression without nephrotoxicity. It is possible that maintaining blood level between defined limits would improve results.Keywords
This publication has 15 references indexed in Scilit:
- NEPHROTOXICITY OF CYCLOSPORIN AThe Lancet, 1981
- Segmental pancreas transplantation from living related and cadaver donors: a clinical experience.1981
- Improved survival after orthotopic liver grafting.BMJ, 1981
- Cyclosporin A in cadaveric organ transplantation.BMJ, 1981
- A LONG-TERM FUNCTIONING HUMAN PANCREATIC ISLET ALLOTRANSPLANTTransplantation, 1980
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- Ten Year Experience with Renal Transplantation in Juvenile Onset DiabeticsAnnals of Surgery, 1979
- IDIOPATHIC CARDIOMYOPATHY, AGE, AND SUPPRESSOR-CELL DYSFUNCTION AS RISK DETERMINANTS OF LYMPHOMA AFTER CARDIAC TRANSPLANTATIONThe Lancet, 1978
- PROLONGED SURVIVAL OF PIG ORTHOTOPIC HEART GRAFTS TREATED WITH CYCLOSPORIN AThe Lancet, 1978
- NEW METHOD OF PREPARATION OF SEGMENTAL PANCREATIC GRAFTS FOR TRANSPLANTATION - TRIALS IN DOGS AND IN MAN1978